Early intravenous gamma-globulin treatment for Kawasaki disease: The nationwide surveys in Japan [3] (multiple letters)

Journal of Pediatrics

Volumn 146, Issue 1, 2005, Pages 149-150

  Wanitkun, Suthep ^a   Muta, Hiromi ^b   Ishii, Masahiro ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; STEROID;

CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; ECHOCARDIOGRAPHY; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; JAPAN; LETTER; MEDICAL LITERATURE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATIENT SELECTION; PRIORITY JOURNAL; SAMPLE SIZE; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE;

EID: 11844254754     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.07.018     Document Type: Letter

References (4)

1. H. Muta M. Ishii K. Egami J. Furui Y. Sugahara T. Akagi Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan J Pediatr 144 2004 496 499
2. H. Yanagawa Y. Nakamura K. Sakata M. Yashiro Use of intravenous gamma-globulin for Kawasaki disease: effects on cardiac sequelae Pediatr Cardiol 18 1997 19 23
3. S. Tse E. Silverman B. McCrindle R. Yeung Early treatment with intravenous immunoglobulin in patients with Kawasaki disease J Pediatr 140 2002 450 455
4. R. Sundel A. Baker D. Fulton J. Newburger Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial J Pediatr 142 2003 611 616